Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot phase 1/2 study of oral Zygosid-50 for glycemic control in type 2 diabetes mellitus
MOH_2026-05-28_016852Phase 2Recruiting
- Sponsor
- Concenter BioPharma
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Zygosid-50 with Placebo (2 arms). Started Jan 2024; status: recruiting.
02
Drugs
Zinc desferrioxamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on MOH_2026-05-28_016852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2026-05-28_016852.